The Newport Beach, California–based company designed its system with state-of-the-art 3D stereoscopic technology. It offers practitioners in dentistry and medicine precision and live 3D visualization.
Surgeons and dentists can move from traditional fixed magnification to NuLoupes high-resolution variable digital magnification. It provides them with more versatility and viewing area. Additionally, NuEyes’ patent-pending camera system provides 3D stereoscopic imaging with near-zero latency.
According to a news release, the camera could offer sub-millimeter accurate depth perception for better environmental understanding. NuEyes says its glasses are the first that feature live 3D stereoscopic imaging to receive an FDA nod.
NuEyes offers the NuLoupes developer kit with a complete SDK that offers exclusive access to a number of features. Those include the 3D stereoscopic camera sensors, IR sensor, IMU, android operating system, Unity plug-ins and more. The company plans to begin shipping developer kits in the first quarter of 2024.
“We are thrilled to announce the FDA approval of NuLoupes, a testament to our commitment to innovation and excellence in the medical technology field,” said Mark Greget, founder and CEO of NuEyes. “NuLoupes represents a huge leap forward in visualization technology, and we are confident that they will revolutionize the way medical professionals approach their work.”
